Aquestive Therapeutics Inc

XNAS:AQST

6.82

+0.16 (+2.40%)

7:21:03 PM EDT: $6.80 -0.02 (-0.29%)

Market Cap (Intraday)	825.02M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$12.97 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$6.78
50-Day MA	$5.65
200-Day MA	$3.80

See more pivots

Aquestive Therapeutics Inc Stock, XNAS:AQST

30 Technology Drive, Warren, New Jersey 07059

United States of America

Phone: +1.908.941.1900

Number of Employees: 142

http://www.aquestive.com

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patientsÃ¢â?¬â?¢ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.